1. Dajani, A S: Rheumatic Fever, in Heart Disease,
5th ed, E Braunwald (ed). Philadelphia, Saunders, 1997, pp. 1769-1775.
2. Coblyn, J S, Weinblatt, M E, in Heart Disease, 5th ed, E
Braunwald (ed).Philadelphia, Saunders, 1997, pp.1776-1785.
3. Bisno, A L: Rheumatic Fever, in Textbook of Rheumatology, 4th ed,
W N Kelley (ed), Philadelphia, Saunders, 1993, pp. 1209-1223.
4. Kaplan, E L: Rheumatic Fever, in Harrison´s Principles of
Internal Medicine, 14th ed, J D Wilson (ed), McGraw-Hill, 1998, pp. 1496-1498.
5. Taranta, A: Fiebre reumática, en Medicina Interna, J H Stein
(ed), Filadelfia, Little, Brown and Company, 1983, pp.1130-1135.
6. Bisno, A L: Nonsuppurative poststreptococcal sequelae: Rheumatic
Fever and Glomerulonephritis, in Principles and practice of infectious Disease, 4th ed, G
L Mandell (ed), Churchill Livingstone Inc, 1995, pp. 1799-1810.
7. Sierra López, A y Torres Lana, A: Enfermedades cardiovasculares.
Estrategias de prevención y control; Enfermedades crónicas e incapacitantes, en Medicina
preventiva y Salud pública, 9ª ed, G Piédrola Gil (ed), Barcelona, Masson,1991,
pp.840-841 y 849-850.
8. "Jones criteria (revised) for guidance in the diagnosis of
rheumatic fever". Circulation, 1984, 69:204A-208A.
9. Dajani, A S, Bisno, A L, Chung, K J, et al. prevention of
rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever,
Endocarditis, and Kawasiki Disease of the Council on Cardiovascular Disease in the Young,
the American heart Association, Circulation,1988, 78: 1082.1086.
10. Dajani, S, Bisno, K y Hunds, P. Prevention of Rheumatic Fever,
Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the Young;
the American Heart Association. Pedatr Infect Dis J, 1989, 8: 263-266.
11. O.M.S. Serie de Informes Técnicos nº 764. Fiebre Reumática y
Cardiopatía Reumática. Ginebra, 1988.
12. Bisno, A L. Group A streptococal infections and acute Rheumatic
Fever. N Engl J Med, 1991, 325 (II): 783-791.
13. A Report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines (Committee on Management of Patients With
Valvular Heart Disease). Guidelines for the Management of Patients With Valvulat heart
Disease, Circulation, 1998, 98: 1949-1984.
14. Gómez-Reino, F J, y Gómez-Reino, J J. Estado actual y
prevención de la fiebre reumática. An.Esp.Pediat, 1991, 34 (2): 97-102.
15. Dale, J, y Beachey, E. Multiple heart cross-reactive epitopes of
streptococcal M proteins. J Exp Med, 1985,161:113-122.
16. Odio, A. Giardina, A C. Veasy, L G y Hill, H. Resurgence of
Acute Rheumatic Fever. Letter to the editor. N Engl J Med, 1987,317:508-507.
17. Peña Castiñeira, F J. Mortalidad por fiebre y cardiopatía
reumática: Estudio comparativo entre Galicia y España (decenio 1967/1976): Rev San Hig
Pub, 1987, 61: 339-354.
18. Cortina Greus, P, Alfonso Sánchez, J L y cols. Evolución
epidemiológica de la fiebre reumática y cardiopatía reumática en españa (1951-1986).
Rev San Hig Pub, 1991, 65: 17-24.
19. Gordis, L. The virtual disappearance of rheumatic fever in the
United States: lessons in the rise and fail of disease. Circulation, 1985, 72:1155-1162.
20. Massell, B F, Chute, C G, Walker, A M, Kurland, G S. Penicilin
and the marked decreases in morbidity and mortality from rheumatic fever in the United
States. N Engl J Med, 1988, 318: 280-286.
21. Markowitz, M. The decline of rheumatic fever: role of medical
intervention. J Pediatr, 1985, 106: 545-550.
